FDA Approved: RYZUMVI — Original Application (Oyster Point Pharma, Inc.)

View source ↗

Summary

FDA approved RYZUMVI (phentolamine mesylate) from Oyster Point Pharma as an injectable product to treat vasopressor-induced extravasation injuries.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vasopressor-induced Extravasation Injury

Drugs mentioned

• RYZUMVI (phentolamine mesylate)

Snippet

ORIG AP for RYZUMVI (PHENTOLAMINE MESYLATE)